To identify a biomarker or biomarker-set for adverse metabolic effects of various doses of prednisolone Day 1 and day 15 [clinicaltrials_resource:67d0d53b59802ce1f53755f5582a31f1]
Treatment with placebo for 15 days
clinicaltrials_vocabulary:secondary outcome [clinicaltrials_vocabulary:clinicaltrials_vocabulary:secondary-outcome]
To identify a biomarker or biomarker-set for adverse metabolic effects of various doses of prednisolone Day 1 and day 15 [clinicaltrials_resource:67d0d53b59802ce1f53755f5582a31f1]
Treatment with placebo for 15 days
Bio2RDF identifier
67d0d53b59802ce1f53755f5582a31f1
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:67d0d53b59802ce1f53755f5582a31f1
measure [clinicaltrials_vocabulary:measure]
To identify a biomarker or bio ...... various doses of prednisolone
time frame [clinicaltrials_vocabulary:time-frame]
Day 1 and day 15
description
Treatment with placebo for 15 days
identifier
clinicaltrials_resource:67d0d53b59802ce1f53755f5582a31f1
title
To identify a biomarker or bio ...... prednisolone Day 1 and day 15
@en
type
label
To identify a biomarker or bio ...... 0d53b59802ce1f53755f5582a31f1]
@en